Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMAH1G7)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Patented Agent(s)

Download the Complete Related Drug List

Drug(s) Targeting Lysine-specific demethylase 4 (KDM4)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
N-oxalylglycine derivative 2	DMDJC96	N. A.	N. A.	Patented	[1]
Pyridine-2,4-dicarboxylic acid derivative 1	DMZSTCQ	N. A.	N. A.	Patented	[1]
Hydroxamate analog 3	DMDQYJ1	N. A.	N. A.	Patented	[1]
PMID25468267-Compound-51	DMNPC0H	N. A.	N. A.	Patented	[1]
PMID25468267-Compound-54	DMI93AX	N. A.	N. A.	Patented	[1]
N-oxalylglycine derivative 3	DMQF0RY	N. A.	N. A.	Patented	[1]
PMID25468267-Compound-48	DMBPT9Z	N. A.	N. A.	Patented	[1]
Pyridine-2,4-dicarboxylic acid derivative 2	DMGCMF5	N. A.	N. A.	Patented	[1]
2,2-bipyridyl derivative 5	DMEJOPL	N. A.	N. A.	Patented	[1]
Pyridine-2,4-dicarboxylic acid derivative 3	DMCUP4L	N. A.	N. A.	Patented	[1]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Lysine-specific demethylase 4 (KDM4)	TT0RGE9	NOUNIPROTAC	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.Expert Opin Ther Pat. 2015 Feb;25(2):135-44.